Caps prescription drug prices for millions of Americans by setting federal limits.
This bill would set federal price limits for prescription drugs. It would cap how much drug manufacturers can charge for medications, affecting people on federal health programs like Medicare and Medicaid, as well as those with private insurance or no insurance.
Today, there are no federal rules that cap prescription drug prices across all government health programs or for all individuals, including those without insurance or with private plans. If this bill becomes law, the government would set annual maximum "reference prices" for prescription drugs. Drug manufacturers would then be required to sell drugs at or below these set prices to everyone, potentially lowering costs for millions of Americans.
S 1753 · 119th Congress · May 14, 2025 · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers
4 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.